Loading...

← Back to Leaderboard

Neeraj Sood

Global rank #3478 96%

Institution: University of Southern California

Primary Field: Health (weighted toward more recent publications)

First Publication: 2002

Most Recent: 2026

RePEc ID: pso62 ↗

Publication Scores

Scores use coauthorship adjustment: α/n credit per paper, where n = number of authors. α = 2.01: calibrated so average adjusted count equals average raw count (a zero-sum adjustment).

Period S (4x) A (2x) B (1x) C (½x) Total
Last 5 Years 0.00 1.34 1.91 0.00 4.59
Last 10 Years 0.00 1.84 3.62 0.00 7.31
All Time 0.67 4.86 8.45 0.00 22.02

Publication Statistics

Raw Publications 26
Coauthorship-Adjusted Count 16.39

Publications (26)

Year Article Journal Tier Authors
2026 Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market American Economic Journal: Applied Economics A 3
2025 Back to school: The effect of school visits during COVID-19 on COVID-19 outcomes Journal of Health Economics B 4
2023 The impact of COVID‐19 shelter‐in‐place policy responses on excess mortality Health Economics B 4
2023 Prescription drug advertising and drug utilization: The role of Medicare Part D Journal of Public Economics A 3
2022 The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data Journal of Health Economics B 5
2021 Effects of employer-offered high-deductible plans on low-value spending in the privately insured population Journal of Health Economics B 4
2018 Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? American Economic Journal: Economic Policy A 4
2017 The long term effects of “Consumer-Directed” health plans on preventive care use Journal of Health Economics B 5
2017 Financial risk protection from social health insurance Journal of Health Economics B 4
2017 Effects of payment reform in more versus less competitive markets Journal of Health Economics B 5
2016 Do “Consumer-Directed” health plans bend the cost curve over time? Journal of Health Economics B 5
2015 The Impact of Insurance on HIV Testing American Journal of Health Economics B 3
2014 Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems Journal of Health Economics B 5
2013 Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development Journal of Public Economics A 2
2013 Pharmaceutical advertising and Medicare Part D Journal of Health Economics B 3
2013 Health insurance as a two-part pricing contract Journal of Public Economics A 2
2013 The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities Journal of Health Economics B 5
2010 Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior Journal of Law and Economics B 3
2009 Market evidence of misperceived mortality risk Journal of Economic Behavior and Organization B 3
2009 Innovation and the welfare effects of public drug insurance Journal of Public Economics A 2
2008 Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system Journal of Health Economics B 3
2006 HIV Breakthroughs and Risky Sexual Behavior Quarterly Journal of Economics S 3
2005 The reallocation of compensation in response to health insurance premium increases Economics Letters C 3
2004 Social insurance and the design of innovation incentives Economics Letters C 2
2003 The link between public and private insurance and HIV-related mortality Journal of Health Economics B 3
2002 Optimal contributions to flexible spending accounts Economics Letters C 3